Protocol: L002G
______________________________________________________________________________
| 784 |L03AB07| INTERFERONUM BETA 1a**** | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L03AB07 INTERFERONUM BETA 1a SOL. INJ. 22 µg/0,5 ml
REBIF 22 µg 22 µg/0,5 ml SERONO EUROPE LTD.
L03AB07 INTERFERONUM BETA 1a PULB. + SOLV. PT. SOL. 30 µg (6 mil. UI)
INJ.
AVONEX 30 µg BIO-SET 30 µg (6 mil. UI) BIOGEN IDEC LIMITED
L03AB07 INTERFERONUM BETA 1a SOL. INJ. 44 µg
REBIF 44 µg 44 µg SERONO EUROPE LTD.
________________________________________________________________________________
______________________________________________________________________________
| 785 |L03AB08| INTERFERONUM BETA 1B**** | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L03AB08 INTERFERONUM BETA 1B PULB. + SOLV. PT. SOL. 250 µg/ml
INJ.
BETAFERON 250 µg/ml 250 µg/ml BAYER SCHERING AG
________________________________________________________________________________
______________________________________________________________________________
| 786 |L03AX13| GLATIRAMER ACETAT**** | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L03AX13 GLATIRAMER ACETAT SOL. INJ. 20 mg/ml
COPAXONE 20 mg/ml TEVA PHARMACEUTICALS
S.R.L.
________________________________________________________________________________
______________________________________________________________________________
| 787 |L04AA23| NATALIZUMABUM**** | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L04AA23 NATALIZUMABUM CONC. PT. SOL. PERF. 20 mg/ml
TYSABRI 300 mg 20 mg/ml ELAN PHARMA INTERNATIONAL
LTD
A fost raportat la acest medicament leucoencefalopatie multifocală progresivă.
________________________________________________________________________________
______________________________________________________________________________
| 788 |L04AX01| AZATHIOPRINUM* | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg
IMURAN(R) 50 mg THE WELLCOME FOUNDATION
LTD.
________________________________________________________________________________
SUBLISTA C2 - P5: PROGRAMUL NAŢIONAL DE DIABET ZAHARAT.
Protocol: AE01E
______________________________________________________________________________
| 789 |A10AB01| INSULINE UMANE | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AB01 INSULINE UMANE SOL. INJ. 100 UI/ml
HUMULIN R 100 UI/ml LILLY FRANCE SAS
A10AB01 INSULINE UMANE SOL. INJ. 100 UI/ml
HUMULIN R 100 UI/ml LILLY FRANCE SAS
A10AB01 INSULINE UMANE SOL. INJ. ÎN CARTUŞ 100 UI/ml
ACTRAPID PENFILL 100 UI/ml 100 UI/ml NOVO NORDISK A/S
INSUMAN RAPID 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AB01 INSULINE UMANE SOL. INJ. ÎN FLACON 100 UI/ml
ACTRAPID 100 UI/ml 100 UI/ml NOVO NORDISK A/S
INSUMAN RAPID 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AB01 INSULINE UMANE SOL. INJ. ÎN FLACON 100 UI/ml
ACTRAPID 100 UI/ml 100 UI/ml NOVO NORDISK A/S
INSUMAN RAPID 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AB01 INSULINE UMANE SOL. INJ. ÎN STILOU 100 UI/ml
INJECTOR PREUMPLUT
ACTRAPID NOVOLET 100 UI/ml 100 UI/ml NOVO NORDISK A/S
INSUMAN RAPID 100 UI/ml SANOFI - AVENTIS
100 UI/ml OPTISET DEUTSCHLAND GMBH
________________________________________________________________________________
______________________________________________________________________________
| 790 |A10AB04| INSULINUM LISPRO** | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AB04 INSULINUM LISPRO SOL. INJ. 100 U/ml
HUMALOG 100 U/ml 100 U/ml ELI LILLY NEDERLAND BV
________________________________________________________________________________
______________________________________________________________________________
| 791 |A10AB05| INSULINUM ASPART** | Protocol: A016E |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AB05 INSULINUM ASPART SOL. INJ. ÎN CARTUŞ 100 Uml
NOVORAPID PENFILL 100 U/ml 100 Uml NOVO NORDISK A/S
________________________________________________________________________________
______________________________________________________________________________
| 792 |A10AB06| INSULINUM GLULIZINA** | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AB06 INSULINUM GLULIZINA SOL. INJ. ÎN CARTUŞ 100 U/ml
APIDRA 100 U/ml 100 U/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AB06 INSULINUM GLULIZINA SOL. INJ. ÎN FLACON 100 U/ml
APIDRA 100 U/ml 100 U/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AB06 INSULINUM GLULIZINA SOL. INJ. ÎN STILOU 100 U/ml
INJECTOR PREUMPLUT
APIDRA 100 U/ml 100 U/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
________________________________________________________________________________
______________________________________________________________________________
| 793 |A10AC01| INSULINE UMANE | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AC01 INSULINE UMANE SUSP. INJ. 100 UI/ml
HUMULIN N 100 UI/ml LILLY FRANCE SAS
A10AC01 INSULINE UMANE SUSP. INJ. ÎN STILOU 100 UI/ml
INJECTOR PREUMPLUT
INSULATARD NOVOLET 100 UI/ml 100 UI/ml NOVO NORDISK A/S
INSUMAN BASAL 100 UI/ml SANOFI - AVENTIS
100 UI/ml OPTISET DEUTSCHLAND GMBH
A10AC01 INSULINE UMANE SUSP. INJ. ÎN CARTUŞ 100 UI/ml
INSULATARD PENFILL 100 UI/ml 100 UI/ml NOVO NORDISK A/S
INSUMAN BASAL 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AC01 INSULINE UMANE SUSP. INJ. ÎN FLACON 100 UI/ml
INSULATARD 100 UI/ml 100 UI/ml NOVO NORDISK A/S
INSUMAN BASAL 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AC01 INSULINE UMANE SUSP. INJ. ÎN FLACON 100 UI/ml
INSULATARD 100 UI/ml 100 UI/ml NOVO NORDISK A/S
INSUMAN BASAL 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
________________________________________________________________________________
______________________________________________________________________________
| 794 |A10AC04| INSULINUM LISPRO** | Protocol: A029E |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AC04 INSULINUM LISPRO SOL. INJ. 100 U/ml
HUMALOG NPL 100 U/ml 100 U/ml ELI LILLY NEDERLAND BV
________________________________________________________________________________
______________________________________________________________________________
| 795 |A10AD01| INSULINE UMANE | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AD01 INSULINE UMANE SUSP. INJ.
HUMULIN M3 100 ui/ml LILLY FRANCE S.A.S.
A10AD01 INSULINE UMANE SUSP. INJ. ÎN STILOU 100 UI/ml
INJECTOR PREUMPLUT
INSUMAN COMB 25 100 UI/ml SANOFI - AVENTIS
100 UI/ml OPTISET DEUTSCHLAND GMBH
INSUMAN COMB 50 100 UI/ml SANOFI - AVENTIS
100 UI/ml OPTISET DEUTSCHLAND GMBH
MIXTARD 30 NOVOLET 100 Ul/ml 100 UI/ml NOVO NORDISK A/S
A10AD01 INSULINE UMANE SUSP. INJ. ÎN CARTUŞ 100 UI/ml
INSUMAN COMB 25 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
INSUMAN COMB 50 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
MIXTARD 20 PENFILL 100 UI/ml 100 UI/ml NOVO NORDISK A/S
MIXTARD 30 PENFILL 100 UI/ml 100 UI/ml NOVO NORDISK A/S
MIXTARD 40 PENFILL 100 UI/ml 100 UI/ml NOVO NORDISK A/S
A10AD01 INSULINE UMANE SUSP. INJ. ÎN FLACON 100 UI/ml
INSUMAN COMB 25 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
INSUMAN COMB 50 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
MIXTARD 30 100 UI/ml 100 UI/ml NOVO NORDISK A/S
A10AD01 INSULINE UMANE SUSP. INJ. ÎN FLACON 100 UI/ml
INSUMAN COMB 25 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
INSUMAN COMB 50 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
MIXTARD 30 100 UI/ml 100 UI/ml NOVO NORDISK A/S
________________________________________________________________________________
______________________________________________________________________________
| 796 |A10AD04| INSULINUM LISPRO** | Protocol: A015E |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AD04 INSULINUM LISPRO SUSP. INJ. 100 U/ml
HUMALOG MIX25 100 U/ml ELI LILLY NEDERLAND BV
HUMALOG MIX50 100 U/ml ELI LILLY NEDERLAND BV
________________________________________________________________________________
______________________________________________________________________________
| 797 |A10AD05| INSULINUM ASPART** | Protocol: A018E |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AD05 INSULINUM ASPART SUSP. INJ. ÎN STILOU 100 UIml
INJECTOR PREUMPLUT
NOVOMIX 30 FLEXPEN 100 UIml NOVO NORDISK A/S
________________________________________________________________________________
______________________________________________________________________________
| 798 |A10AE04| INSULINUM GLARGINE** | Protocol: A024E |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AE04 INSULINUM GLARGINE SOL. INJ. ÎN CARTUŞ 100 UI/ml
LANTUS 100 UI/ml 100 UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AE04 INSULINUM GLARGINE SOL. INJ. ÎN FLACON 100 UI/ml
LANTUS 100 UI/ml 10O UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
A10AE04 INSULINUM GLARGINE SOL. INJ. ÎN STILOU 100 UI/ml
INJECTOR PREUMPLUT
LANTUS OptiSet 10O UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
LANTUS SoloStar 10O UI/ml SANOFI - AVENTIS
DEUTSCHLAND GMBH
________________________________________________________________________________
______________________________________________________________________________
| 799 |A10AE05| INSULINUM DETEMIR** | Protocol: A023E |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10AE05 INSULINUM DETEMIR SOL. INJ. ÎN CARTUŞ 100 U/ml
LEVEMIR PENFILL 100 U/ml 100 U/ml NOVO NORDISK A/S
A10AE05 INSULINUM DETEMIR SOL. INJ. ÎN STILOU 100 U/ml
INJECTOR PREUMPLUT
LEVEMIR FLEXPEN 100 U/ml 100 U/ml NOVO NORDISK A/S
________________________________________________________________________________
______________________________________________________________________________
| 800 |A10BA02| METFORMINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10BA02 METFORMINUM COMPR. 1000 mg
METFORMIN 1000 mg 1000 mg ARENA GROUP SA
A10BA02 METFORMINUM COMPR. FILM. 1000 mg
GLUCOPHAGE 1000 mg 10OO mg MERCK SANTE
METFOGAMMA 1000 mg 1000 mg WORWAG PHARMA
GMBH & CO. KG
SIOFOR 1000 1000 mg BERLIN CHEME AG MENARINI
GROUP
A10BA02 METFORMINUM COMPR. PT. SOL. ORALA 1000 mg
FORMIRAN 1000 mg 1000 mg TERAPIA SA
A10BA02 METFORMINUM COMPR. 500 mg
DIGUAN(R) 500 mg 500 mg ZENTIVA SA
METFORMIN 500 mg 500 mg ARENA GROUP SA
A10BA02 METFORMINUM COMPR. ELIB. PREL 500 mg
GLUCOPHAGE XR 500 mg MERCK SANTE S.A.S.
A10BA02 METFORMINUM COMPR. FILM. 500 mg
DIPIMET 500 mg 500 mg ANTIBIOTICE SA
GLUCOPHAGE 500 500 mg MERCK SANTE
MEGUAN(R) 500 mg 500 mg GEDEON RICHTER ROMANIA SA
METFOGAMMA(R) 500 500 mg WORWAG PHARMA
GMBH & CO. KG
METFORMIN AL 500 500 mg ALIUD PHARMA GMBH & CO. KG
METFORMIN LPH(R) 500 mg 500 mg LABORMED PHARMA SA
METFORMIN-TEVA 500 mg 500 mg TEVA PHARMACEUTICAL S.R.L.
A10BA02 METFORMINUM COMPR. PT. SOL. ORALA 500 mg
FORMIRAN 500 mg 500 mg TERAPIA S.A.
A10BA02 METFORMINUM COMPR. 850 mg
DIAFORMIN(R) 850 mg 850 mg TERAPIA SA
METFORMIN 850 mg 850 mg ARENA GROUP SA
A10BA02 METFORMINUM COMPR. FILM. 850 mg
GLUCOPHAGE 850 mg 850 mg MERCK SANTE
MEDIFOR 850 850 mg STD CHEMICALS LTD.
MEGUAN(R) 850 mg 850 mg GEDEON RICHTER ROMANIA SA
METFOGAMMA 850 850 mg WORWAG PHARMA
GMBH & CO. KG
METFORMIN AL 850 850 mg ALIUD PHARMA GMBH & CO. KG
METFORMIN LPH(R) 850 mg 850 mg LABORMED PHARMA SA
METFORMIN-TEVA 850 mg 850 mg TEVA PHARMACEUTICAL S.R.L.
SIOFOR(R) 850 850 mg BERLIN CHEME AG MENARINI
GROUP
A10BA02 METFORMINUM COMPR. PT. SOL. ORALA 850 mg
FORMIRAN 850 mg 850 mg TERAPIA S.A.
________________________________________________________________________________
______________________________________________________________________________
| 801 |A10BA03| BUFORMINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10BA03 BUFORMINUM DRAJ. RET. 100 mg
SILUBIN RETARD 100 mg DITA IMPORT EXPORT SRL
________________________________________________________________________________
______________________________________________________________________________
| 802 |A10BB01| GLIBENCLAMIDUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10BB01 GLIBENCLAMIDUM COMPR. 1,75 mg
GLIBENCLAMID 1,75 mg ANTIBIOTICE S.A.
ANTIBIOTICE 1,75 mg
A10BB01 GLIBENCLAMIDUM COMPR. 1.75 mg
GLIBENCIAMID LPH 1,75 mg 1.75 mg LABORMED PHARMA SA
GLIBENCLAMID ARENA 1,75 mg 1.75 mg ARENA GROUP SA
MANINIL 1,75 mg 1.75 mg BERLIN CHEME AG MENARINI
GROUP
A10BB01 GLIBENCLAMIDUM COMPR. 3,5 mg
GLIBENCIAMID 3,5 mg ANTIBIOTICE SA
ANTIBIOTICE 3,5 mg
A10BB01 GLIBENCLAMIDUM COMPR. 3.5 mg
GLIBENCIAMID ARENA 3,5 mg 3.5 mg ARENA GROUP SA
GLIBENCIAMID LPH 3,5 mg 3.5 mg LABORMED PHARMA SA
MANINIL 3,5 mg 3.5 mg BERLIN CHEME AG MENARINI
GROUP
A10BB01 GLIBENCLAMIDUM COMPR. 5 mg
GLIBENCIAMID 5 mg 5 mg ARENA GROUP SA
________________________________________________________________________________
______________________________________________________________________________
| 803 |A10BB03| TOLBUTAMIDUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10BB03 TOLBUTAMIDUM COMPR. 500 mg
TOLBUTAMID 500 mg SINTOFARM SA
________________________________________________________________________________
______________________________________________________________________________
| 804 |A10BB07| GLIPIZIDUM | |
|_______|_______|____________________________________________|_________________|
Sulfonilurea poate cauza hipoglicemie, în mod particular la vârstnici.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10BB07 GLIPIZIDUM COMPR. FILM. ELIB. 10 mg
MODIF.
GLUCOTROL XL 10 mg 10 mg PFIZER EUROPE MA EEIG
A10BB07 GLIPIZIDUM COMPR. 5 mg
GLIPIZID LPH 5 mg 5 mg LABORMED PHARMA SA
A10BB07 GLIPIZIDUM COMPR. FILM. ELIB. 5 mg
MODIF.
GLUCOTROL XL 5 mg 5 mg PFIZER EUROPE MA EEIG
________________________________________________________________________________
______________________________________________________________________________
| 805 |A10BB08| GLIQUIDONUM | |
|_______|_______|____________________________________________|_________________|
Sulfonilurea poate cauza hipoglicemie, în mod particular la vârstnici.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10BB08 GLIQUIDONUM COMPR. 30 mg
GLURENORM 30 mg BOEHRINGER INGELHEIM INT.
GMBH
________________________________________________________________________________
______________________________________________________________________________
| 806 |A10BB09| GLICLAZIDUM | |
|_______|_______|____________________________________________|_________________|
Sulfonilurea poate cauza hipoglicemie, în mod particular la vârstnici
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
A10BB09 GLICLAZIDUM COMPR. ELIB. MODIF. 30 mg
DIAPREL MR 30 mg LES LABORATOIRES SERVER
A10BB09 GLICLAZIDUM COMPR. ELIB. PREL 30 mg
GLICLAZID MR LPH 30 mg 30 mg LABORMED PHARMA SA
A10BB09 GLICLAZIDUM COMPR. 80 mg
DIABREZIDE 80 mg L. MOLTENI
ESQUEL(R) 80 mg 80 mg GEDEON RICHTER ROMANIA SA
GLICLAZID LPH 80 mg LABORMED PHARMA SA
GLIDIET 80 mg MEDICAROM GROUP S.R.L.
A10BB09 GLICLAZIDUM COMPR. DIVIZ. 80 mg
DIAPREL 80 mg LES LABORATOIRES SERVER
________________________________________________________________________________
______________________________________________________________________________
| 807 |A10BB12| GLIMEPIRIDUM | |
|_______|_______|____________________________________________|_________________|
Sulfonilurea poate cauza hipoglicemie, în mod particular la vârstnici
Dostları ilə paylaş: |